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Abstract
Two groups with three wild boars each were used: Group A (animals 1 to 3) served as the
control, and Group B (animals 4 to 6) was postnatally persistently infected with the Cat01
strain of CSFV (primary virus). The animals, six weeks old and clinically healthy, were inoc-
ulated with the virulent strain Margarita (secondary virus). For exclusive detection of the
Margarita strain, a specific qRT-PCR assay was designed, which proved not to have cross-
reactivity with the Cat01 strain. The wild boars persistently infected with CSFV were pro-
tected from superinfection by the virulent CSFV Margarita strain, as evidenced by the
absence of clinical signs and the absence of Margarita RNA detection in serum, swabs and
tissue samples. Additionally, in PBMCs, a well-known target for CSFV viral replication, only
the primary infecting virus RNA (Cat01 strain) could be detected, even after the isolation in
ST cells, demonstrating SIE at the tissue level in vivo. Furthermore, the data analysis of the
Margarita qRT-PCR, by means of calculated ΔCt values, supported that PBMCs from per-
sistently infected animals were substantially protected from superinfection after in vitro inoc-
ulation with the Margarita virus strain, while this virus was able to infect naive PBMCs
efficiently. In parallel, IFN-α values were undetectable in the sera from animals in Group B
after inoculation with the CSFV Margarita strain. Furthermore, these animals were unable to
elicit adaptive humoral (no E2-specific or neutralising antibodies) or cellular immune
responses (in terms of IFN-γ-producing cells) after inoculation with the second virus. Finally,
a sequence analysis could not detect CSFV Margarita RNA in the samples tested from
Group B. Our results suggested that the SIE phenomenon might be involved in the evolution
and phylogeny of the virus, as well as in CSFV control by vaccination. To the best of our
knowledge, this study was one of the first showing efficient suppression of superinfection in
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animals, especially in the absence of IFN-α, which might be associated with the lack of
innate immune mechanisms.
1. Introduction
Members of the Pestivirus genus, within the Flaviviridae family, account for a variety of dis-
eases in farm animals, the most economically important of which are bovine viral diarrhoea
virus (BVDV) and classical swine fever virus (CSFV). Classical swine fever virus (CSFV) is the
etiological agent of a highly contagious viral disease of swine affecting domestic pigs and wild
boars [1], which has caused major losses in stock farming [2, 3]. CSFV is composed of a lipid
envelope, a capsid and a single plus-strand RNA genome carrying a single, large open reading
frame (ORF) flanked by two untranslated regions (UTRs). The ORF encodes a polyprotein of
approximately 3900 amino acids, which are processed by cellular and viral proteases in the
four structural proteins—C, Erns, E1, E2—and in the 8 non-structural proteins—Npro, P7, NS2,
NS3, NS4A, NS4B, NS5A, and NS5B [4].
Recently, it was proved that CSFV can generate postnatal persistence by infecting both new-
born piglets and wild boars with either low- and/or moderate-virulence strains, respectively.
Over the six weeks after postnatal infection, most of the infected animals remained clinically
healthy, despite persistent high virus titres in the blood, organs and body secretions. Impor-
tantly, these animals were unable to mount any detectable humoral or cellular immune
responses. At necropsy, the most prominent gross pathological lesion was severe thymus atro-
phy. Four weeks after infection, PBMCs from persistently infected seronegative piglets were
unresponsive to both specific CSFV and non-specific PHA stimulation in terms of IFN-γ-pro-
ducing cells. These results suggested the development of an immunosuppression state in these
postnatally persistently infected pigs [5, 6]. In addition, it was shown that six-week-old, persis-
tently CSFV-infected pigs were unable to elicit specific immune responses following vaccina-
tion with a CSFV lapinised C-strain vaccine (HCLV) [7]. Interestingly, the RNA of the vaccinal
C-strain was undetectable by specific RT-PCR [8] in any of the samples analysed after vaccina-
tion, including blood, nasal and rectal swabs, or organs throughout the experiment, suggesting
a phenomenon of homologous interference, also known as superinfection exclusion (SIE),
between the high viral load generated by the primary persistent infection and the CSFV vaccine
strain.
The SIE phenomenon, defined as the ability of a primary virus infection to interfere with a
secondary infection by the same or a closely related virus, has been described in a broad range
of virus-host systems, including bacteria, plants, and animals, and in important pathogens of
humans, such as rubella virus, human immunodeficiency virus (HIV), and hepatitis C virus
(HCV), among others [9–20]. From an evolutionary standpoint, SIE might be a conservative
strategy, reducing the likelihood of recombination events between related strains [17, 21, 22],
thus determining the stability of viral sequences within the same cell. From a practical stand-
point, SIE has significant implications for the treatment or prevention of viral infections. In
this regard, cross-protection of crops by purposeful infection with milder virus isolates is a
widely accepted practice, and it is viewed as an effective and economical antiviral management
strategy [23]. Additionally, transplantation of HCV-infected liver grafts has been suggested as
a treatment for already infected patients, given that the transplantation of a healthy organ
would lead to rapid damage to the newly transplanted liver by the virus of the recipient patient
[15, 24].
Previous studies conducted in cell cultures with BVDV demonstrated that cells acutely
infected with this virus were protected from a second infection by a homologous BVDV strain
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[17]. Additionally, it was shown that CSFV is generally noncytopathic, and it readily establishes
persistent infections in cell culture. Nevertheless, when persistently infected cultures were seri-
ally passaged more than 100 times, spontaneous generation of cytopathogenic (cp) CSFV vari-
ants could occur. The few surviving cells of the cytopathic effect (CPE), although still infected,
were also protected from the CPE after superinfection with cp CSFV [25]. Both studies sup-
ported the ability of pestiviruses to generate SIE in cell cultures. Thus, along with the availabil-
ity of a persistent infection model of CSFV, in the present study, we sought to assess SIE
against a highly virulent CSFV strain at the organism level in six-week-old wild boars, rendered
persistently CSFV-infected at birth. Our results showed that SIE could occur at the systemic
level in CSFV-infected swine.
2. Materials and Methods
2.1. Cells and viruses
PK-15 cells (ATCC CCL 33) and SK6 cells [26] were cultured in Dulbecco's Modified Eagle
Medium (DMEM), supplemented with 10% foetal bovine serum (FBS), Pestivirus-free, at 37°C
in 5% CO2. The cells were infected with 0.1 TCID50/cell in 2% FBS, and the virus was harvested
48 h later. Additionally, ST cells (ATCC CRL 1746) were cultured in DMEM, supplemented
with L-glutamine (2%) and 10% foetal bovine serum (FBS), Pestivirus-free at 37°C in 5% CO2.
Peroxidase-linked assay (PLA) [27] was used for viral titration following the statistical methods
described by Reed and Muench [28].
The Catalonia 01 (Cat01) strain used in this study was isolated from the Spanish CSF epizo-
otic in 2000–2001 [29]. This isolate belongs to the CSFV 2.3 genogroup [30]. The course of
infection by this strain was found to be mild [29, 31]. Finally, the virulent Margarita strain,
which belongs to the CSFV 1.4 genogroup [29, 32, 33], was used.
2.2. Experimental design
To elucidate the capacity of CSFV to generate SIE, two groups (A and B), with three male, six-
week-old wild boars in each, were used. These animals were acquired from Gestion Cinegetica
Integral SL farm (Segovia, Spain) and were housed in the experimental isolation facilities in the
biosecurity level 3 laboratory of the Centre de Recerca en Sanitat Animal (CReSA); they were
fed a conventional piglet starter diet and pellets until the end of the trial (Startrite 100, Kwik-
start, and Prestarter; SCA Iberica S.A., Zaragoza, Spain) and were handled according to previ-
ous studies conducted in CReSA [6]. Group A (animals 1 to 3) was used as controls, and they
tested Pestivirus-free at the beginning of the study. The second group (Group B), housed in an
independent isolation unit at the BSL-3 facility of CReSA, (animals 4 to 6), were postnatally
persistently CSFV-infected animals. These animals, which had been intranasally infected in the
first 24 h after birth with the CSFV Cat01 strain, were viraemic and apparently healthy at six
weeks old, although being immunosuppressed, they lacked CSFV-specific cellular and humoral
responses [5, 6]. Both groups had an average weight of 6 kg per animal. After a five-day accli-
mation period, all of the animals were experimentally infected by i.m. injection in the neck
[33–35] with 105 TCID50 CSFV Margarita strain. In previous studies, this viral dose caused
acute CSF and often induced death at 10–15 days post-infection (dpi) [36]. Sera and nasal and
rectal swabs were collected at 0, 3, 7, 10 and 13 dpi. Blood samples for the isolation of PBMCs
were obtained at day 0 and at the time of euthanasia.
A trained veterinarian recorded the clinical signs daily in a blinded manner [36]. The clini-
cal signs compatible with CSFV infection were anorexia, fever, conjunctivitis, diarrhoea, consti-
pation, cyanosis of the skin, abdominal petechiae, dyspnoea, tremors, locomotive disturbances,
reluctant walking, swaying movement of the hindquarters, posterior paresis, convulsions from
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mild to severe and prostration. Particular stress was placed upon the registration of nervous
symptoms [29, 33, 34, 36]. The clinical status of the animals was scored from 0 to 6 [29, 33, 34,
36] as follows: 0: no signs; 1: mild pyrexia; 2: pyrexia plus mild clinical signs; 3: mild-to-moder-
ate clinical signs; 4: moderate clinical signs; 5: moderate-to-severe clinical signs; and 6: death.
For ethical reasons, the animals were euthanised when the clinical score reached 5, when exhib-
iting a fall of the hindquarters, when there was inability to drink or feed, when prostration
occurred or when exhibiting moderate nervous disorders. After euthanasia, an exhaustive nec-
ropsy was conducted, in which the presence of pathological symptoms in different organs and
tissues was evaluated. Surviving wild boars were euthanised at 13 dpi, and urine and tissues
(spleen, liver, intestine, mesenteric lymph node, prescapular lymph node, bone marrow,
medulla oblongata, lung, kidney, thymus and tonsil) were obtained at necropsy. Euthanasia
was performed according to European Directive 2010/63/EU, using a pentobarbital overdose
of 60–100 mg/kg administered via the anterior vena cava. The animal care and procedures
were in accordance with the guidelines of the Good Experimental Practices (GEP), under the
supervision of the Ethical and Animal Welfare Committee of the Autonomous University of
Barcelona (UAB), and they were approved under number 8804, according to the existing
national and European regulations. Additionally, the biosafety level of the viruses used in this
study was stated as biosecurity level 3, as approved by the Biosafety Committee of the UAB,
with registration assignment AR-296-15.
2.3. Design and validation of a new qRT-PCR for the detection of
specific CSFVMargarita strain RNA
Fifteen representative sequences of the three CSFV genogroups were retrieved from GenBank
and aligned using BioEdit [37]. Two primers and probes were designed for specific detection of
the Margarita strain sequence (1.4 CSFV genogroup) by targeting the 5´ end of the E2 gene, as
follows: forward primer (2333–2356), 5´-AAGATTACGACCACAATTTACAAC-3´; reverse
primer (2411–2431), 5´-TCC TACTGACCACATTAAGCG-3´ and probe (2369–2389),
5´-CCATCAAGGCTATCTGCACGG-3´. The nucleotide positions were based on the genome
sequence of the Margarita strain (GenBank accession number AJ704817). The probe was labelled
with 6-FAM at the 5´ end and with BHQ1 at the 3´ end. The primers and probe were purified by
reverse phase HPLC. The one-step RT-PCR protocol was undertaken using the commercially
available TaqMan1One-Step RT-PCRMaster Mix Reagents Kit (Applied Biosystems Roche).
The real-time RT-PCR assay was optimised using a total volume of 25 μl. Real-time qRT-PCR
was performed using an Applied Biosystems1 7500 Fast Real-Time PCR System. The tempera-
ture profile was 30 min at 50°C (reverse transcription), 15 min at 95°C (inactivation reverse tran-
scriptase/activation Taq polymerase), followed by 42 cycles of 15 s at 94°C (denaturation), 30 s at
57°C (annealing) and 30 s at 68°C (elongation). Identical temperature profiles were used for all of
the real-time RT-PCR runs, and fluorescence values were collected during the annealing step.
Twenty CSFV RNA preparations strains were used to determine the specificity and sensitivity of
the assay (Table 1) [30, 38]. To exclude the possibility of presence of CSFV Cat01 strain RNA
interfering with the assay sensitivity for the CSFVMargarita strain RNA detection, mixtures
from serial RNA dilutions from both viral strains were analysed. In addition, mixtures from
RNA serum samples of group B (prior to the Margarita strain inoculation), with samples from
group A at 7 days post-infection with the Margarita strain, were analysed.
2.4. Detection of CSFV RNA
RNA was extracted from all of the samples using the NucleoSpin RNA isolation kit (Macherey-
Nagel), according to the manufacturer's instructions. In all cases, RNA was extracted from an
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initial sample volume of 150 μL to obtain a final volume of 50 μL of RNA, which was stored at
-80°C. The presence of CSFV RNA in the serum and in nasal and rectal swabs, as well as in tis-
sue samples, was analysed by a generic CSFV qRT-PCR [39]. This test was used in our labora-
tory for inter-laboratory comparisons of CSFV diagnoses, organised by the EU Reference
Laboratory. Positive results were considered for threshold cycle values (Ct) equal to or less
than 42. Samples in which fluorescence was undetectable were considered negative. Addition-
ally, the qRT-PCR specific for the Margarita strain, designed in this work (described above),
was used to distinguish those samples infected with the Margarita strain.
2.5. Detection of E2-specific and neutralising antibodies
Serum samples were tested with neutralisation peroxidase-linked assay (NPLA) [40], and the
titres were expressed as the reciprocal dilution of serum that neutralised 100 TCID50 of the
Cat01 or Margarita strain in 50% of the culture replicates. The detection of E2-specific antibod-
ies was performed using a commercial ELISA kit (IDEXX); the samples were considered posi-
tive when the blocking percentage was40%, following the manufacturer's recommendations.
2.6. Detection of IFN-α in serum samples
Anti-IFN-αmonoclonal antibodies (K9 and K17) and IFN-α recombinant protein (PBL Biomed-
ical Laboratories, Piscataway, New Jersey, USA) were used in ELISA to detect IFN-α in serum
samples at 0, 3, 7 and 10 dpi [34, 41–43]. The cut-off value of the assay was calculated as the aver-
age of the optical density of negative controls (blank and negative sera before CSFV infection)
plus three standard deviations. Cytokine concentrations in serum were determined using a
regression line built with the optical densities of the cytokine standards used in the tests.
2.7. PBMCs and ELISPOT assay for CSFV-specific IFN-γ-producing
cells
ELISPOT assay to detect CSFV-specific IFN-γ cells was performed as previously described [34],
using PBMCs that were obtained at day 0 and at the time of euthanasia. Briefly, plates (Costar
3590, Corning) were coated overnight with 5 μg/ml capture antibody (P2G10, Pharmigen).
Detection was performed using a biotinylated antibody (P2C11, Pharmigen). A total of 5x105
Table 1. Viruses used in the standardisation of Margarita strain real-time TaqMan assay.
CSFV Genotype/
subtype
References strain/isolate Source
Genotype 1.1 HCLV vaccine (C-strain) (Muñoz-Gonzalez et al.,
2015)
CReSA, Sapin
Genotype 1.4 Margarita CReSA, Spain
Genotype 2.1 Paderborn (CSFV277 reference strain) CReSA, Spain
Genotype 2.2 Clinical samples from experimentally infected pigs with
CSF0018 reference strain (5 samples)
EU Reference Laboratory
for CSF, Germany
CSF573 reference strain (Italy Parna’98) CReSA, Spain
Genotype 2.3 Clinical samples from experimentally infected pigs with
CSF0864 reference strain (4 samples)
EU Reference Laboratory
for CSF, Germany
Clinical samples from experimentally infected pigs with
CSF0634 reference strain (5 samples)
EU Reference Laboratory
for CSF, Germany
Uelzen (CFS639 reference strain) CReSA, Spain
Catalonia 01 (Pérez et al., 2012) CReSA, Spain
Spreda (CSF123 reference strain) CReSA, Spain
doi:10.1371/journal.pone.0149469.t001
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PBMCs/well were plated in triplicate at 0.1 multiplicity of infection (MOI) of the Cat01 and Mar-
garita CSFV strains. Moreover, the same samples were incubated in the presence of phytohae-
magglutinin (PHA) (10 μg/ml). The controls were incubated in the presence of mock-stimulated
wells. The numbers of spots in the media for mock-stimulated wells were considered to constitute
the baseline for the calculation of antigen-specific frequencies of IFN-γ-producing cells.
2.8. Cell culture assay
Samples from animal 1 (Group A: Margarita acutely infected wild boar; 10 dpi), animal 5
(Group B: Cat01 persistently infected wild boar and superinfected with CSFVMargarita strain;
13 dpi), and a Pestivirus-free wild boar (animal 1 before infection), were used to assess SIE in
PBMCs (Fig 1). The PBMCs were isolated from whole blood by centrifugation on Ficoll gradi-
ents (Histopaque-1077; Sigma). The number and viability of the PBMCs were determined by
staining with Trypan blue [33]. A total of 4x105 PBMCs/well from each animal were plated in
quintuplicate at 37°C in 96-well plates with: (i) vehicle; (ii) the Cat01 strain at a 0.1 multiplicity
of infection (MOI); and (iii) the Margarita strain (0.1 MOI). After 72 h, the PBMCs were accu-
rately washed twice and were resuspended in a final volume of 200 μl of PBS per well. To
release the virus from the cells, two freeze-thaw cycles at -80°C were undertaken, and the quin-
tupled samples were harvested in a single aliquot. The presence of virus RNA in PBMC samples
Fig 1. Experimental procedures to examine superinfection exclusion in PBMCs and ST cells.
doi:10.1371/journal.pone.0149469.g001
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was analysed by generic CSFV qRT-PCR [39] and for the specific Margarita strain by qRT-PCR
detection assay (see above, section 2.3). For virus isolation, an established cell line sensitive for
specific CSFV proliferation, ST cells, were cultured at 37°C in 96-well plates in triplicate in the
presence of each of the collected cell suspensions. After 72 h, the supernatants were removed,
and the collected ST cells were washed twice and resuspended in 200 μl of sterile PBS. After
two cycles of freeze-thaw at -80°C, the presence of CSFV RNA in the ST cell samples was ana-
lysed by qRT-PCR for CSFV [39] and the Margarita strain (see above). In parallel, a ST plate
similarly inoculated with cell suspensions was used for confirmation by PLA [27]. A delta Ct
(ΔCt) for Margarita strain RNA detection was calculated as the differences between (i) the
Margarita Ct value detected from the isolation of ST from groups A or B and (ii) the Ct value
in ST inoculated with Margarita-infected naïve PBMC extract, being ΔCt = Ct(a)-Ct (b). The
whole protocol was repeated twice, in ST and also in SK6 cells using PBMCs from animals 1
(Group A), 4 and 5 (group B) and cells from the naïve animal (number 1, Group A), collected
before Margarita infection.
2.9. Sequence analysis
The E2-gene fragment reported by Lowings et al. [44] was amplified by end point RT-PCR [45]
in sera, tonsil, lung and spleen from animals 1, 3 (Group A), 4 and 5 (Group B), collected at
necropsy. Additionally, the viral inoculums used in the experimental infections (Cat01 and
Margarita strains) were evaluated. The amplification products were checked by electrophoresis
on 2% agarose gel and were directly cleaned with a Wizard1 PCR Preps DNA Purification
System (Promega, Madison, Wisconsin, USA). Sequencing reactions were conducted under
BigDyeTM terminator-cycling conditions using an ABI 3130XL. Forward and reverse sequences
obtained from each amplicon were assembled using the Contig Express application in Vector
NTI software, version 11 (Invitrogen). The sequences from the E2-gene fragment obtained
were aligned to analyse the sequence found in each sample.
3. Results
3.1. Specificity and sensitivity of Margarita strain real-time TaqMan assay
Of the 20 CSFV RNA strains analysed, the assay detected only the CSFV RNA from the Marga-
rita strain (1.4 genogroup), while the other 19 CSFV RNA extractions were negative (Table 1).
This result indicated that the newly developed assay was highly specific for the detection of the
CSFVMargarita strain, and there was no cross-reactivity with the other tested CSFV strains from
genogroup 2 (including the Cat01 strain). The specificity of the assay was based primarily on mis-
matches in the probe-binding region but also to some extent on mismatches in primer-binding
regions. The sensitivity of the assay was evaluated by testing 10-fold dilutions of the Margarita
strain RNA. The analytical sensitivity was estimated to be as high as 0.4 TCID50. The assay had a
reaction coefficient (R2) of 0.994 (data not shown). Positive results were considered for threshold
cycle values (Ct) equal to or less than 38. Finally, the presence of Cat01 RNA strain in the sample
containing the Margarita strain RNA did not affect the assay sensitivity (Data not shown).
3.2. Wild boars persistently infected with CSFV were clinically protected
after infection with a CSFV Margarita virulent strain
Animals persistently infected with the Cat01 strain and inoculated with the virulent Margarita
strain (Group B) showed neither clinical signs of disease nor fever at any time throughout the
study, maintaining good health status (Fig 2). In contrast, animals from group A, infected with
the Margarita strain, presented mild clinical signs at 2 dpi that progressed to moderate within
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48–72 h. At 7 dpi, animal 2 showed a clinical score value of 4; however, it was found dead at 8
dpi, with lesions of haemorrhagic diathesis. Animals 1 and 3 progressed to dyspnoea, weight
loss, swaying movement of the hindquarters, posterior paresis and high fever until 10 dpi,
when euthanasia was performed.
3.3. Absence of detectable Margarita strain RNA in CSFV-superinfected
wild boars
Margarita RNA was undetected in the sera from animals in group B, except for animal 4 at 13
dpi with a high Ct value (Ct 36.84), considered a low RNA viral load (36, 39) (Fig 3). Addition-
ally, CSFVMargarita strain RNA could not be detected in any of the nasal or rectal swabs col-
lected from group B (data not shown). Furthermore, in group B, CSFVMargarita RNA was
found only in the liver of animal 4 and also in the spleen of animals 4 and 5, with a low RNA
viral load. In contrast, all wild boars from group B (CSFV persistently infected with Cat01
strain) maintained during the whole trial a high and constant CSFV RNA load in serum, swabs
and organs, when examined by generic CSFV q-RT-PCR (Table 2).
In contrast, both qRT-PCRs (generic and specific for Margarita strain) were positive in
organs and samples collected from animals in group A (Table 2). The Ct values were positive
by the CSFV generic qRT-PCR [39], in both serum and swab samples, from 3 dpi onwards. Ct
values for the specific Margarita assay were similar to those obtained by the CSFV generic
qRT-PCR.
3.4. Absence of humoral response in terms of E2-specific and
neutralising antibodies in CSFV-superinfected animals
To evaluate the induction of CSFV-specific antibodies, serum samples were analysed at differ-
ent times after CSFV Margarita strain infection. The absence of antibody response, in terms of
E2-specific antibodies and neutralising antibody titres, was found in both CSFV acutely and
persistently superinfected groups during the entire experiment (Data not shown).
3.5. Levels of endogenous IFN-α increased with progression of acute
disease but remained undetectable in CSFV-superinfected animals
Previously, it was shown that CSFV PI animals were unable to elicit an innate immune
response, in terms of IFN-α production, against a CSFV life-attenuated vaccine [7]. However,
Fig 2. The animals persistently infected with Cat01 were clinically protected after infection with the
virulent Margarita strain.Means and standard deviations of the daily individual clinical score values after
CSFV virulent Margarita strain infection are represented. Dark grey bars indicate the standard deviation
values for group A. The clinical score values are defined in the Materials and Methods section.
doi:10.1371/journal.pone.0149469.g002
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we wondered whether superinfection with a CSFV virulent strain would trigger detectable lev-
els of IFN-α in the CSFV-superinfected wild boars (Group B), given that IFN-α has been
largely related to disease severity, as a hallmark of CSFV acute infection [34, 46]. In the present
work, we observed that progression of disease in group A was correlated with an increase in the
levels of endogenous IFN-α after infection, as measured by ELISA, with values that reached
more than 240 U/ml in two of three animals at 7 dpi and 10 dpi (data not shown). In contrast,
IFN-α was undetectable in all of the serum samples analysed both before (day 0) and after Mar-
garita inoculation of CSFV Catalonia persistently infected pigs (Group B) (data not shown).
3.6. CSFV-specific IFN-γ-producing cells were lacking in CSFV-
superinfected animals
PBMCs from all of the animals were analysed for virus-specific and non-specific IFN-γ
responses by ELISPOT assay at 0 and 13 dpi post-Margarita strain inoculation. Very few IFN-
γ-producing cells were found upon CSFV and PHA stimulation of PBMCs from all 3 of the
CSFV-superinfected animals (Group B). These results supported our previous results showing
that postnatal infection of piglets with CSFV could result in virus persistence due to a lack of
B- and T-cell responses (data not shown).
Fig 3. Swine persistently infected with the CSFV Cat01 strain were protected from the typical viraemia
generated by the CSFVMargarita strain. (A) Daily detection of CSFV RNA through generic qRT-PCR in
sera [39]. The Ct values from group A (CSFV acutely Margarita-infected wild boars; 1–3) and group B (CSFV-
superinfected wild boars; 4–6) are represented in black and grey colours, respectively. (B) Daily detection of
CSFV RNAMargarita strain through specific qRT-PCR in serum. The Ct mean values from group A (CSFV
acutely infected wild boars; 1–3) and group B (CSFV-superinfected wild boars; 4–6) are represented in black
and grey colours, respectively. Positive results for the CSFV RNA detection [39] were considered for Ct
values equal to or less than 42, indicated with a dashed line. Positive results for the specific CSFV RNA
Margarita strain detection were considered for Ct values equal to or less than 38, indicated with a dotted line
doi:10.1371/journal.pone.0149469.g003
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3.7. CSFV interference in the PBMCs from CSFV-superinfected hosts
It is well known that white blood cells, including the PBMCs, are targets for CSFV replication
[47,48]. Consequently, to examine whether the PBMCs collected from the CSFV-superinfected
animals (group B) and the acutely infected animals (group A), were permissive (or not) to
CSFV superinfection, we assayed in vitro inoculation of such samples, with either Cat01 or
Margarita CSFV strains. Similarly, PBMC samples were mock-infected. Additionally, PBMCs
from a naïve animal were used as controls. As was expected, CSFV-specific Margarita RNA
was detected in the PBMCs from animals developing the CSF acute disease (group A) in both
mock and Margarita-infected samples. Furthermore, PBMCs from group B in vitro inoculated
with Margarita were also positive for CSFV-specific Margarita RNA detection, but with a high
Ct value correlated with a lower RNA load (Table 3). Otherwise, PBMCs from group B in vitro
mock-infected were negative for CSFV-specific Margarita RNA detection (Table 3). Following
these findings, to decipher whether the detected RNA load in group B might correspond to
RNA traces from the inocula or to the infecting virus, the previously analysed PBMC extracts
were inoculated into a ST cell line. Consistently, the detected RNA load notably increased in
ST after inoculation with the extract fromMargarita in vitro inoculated-naïve PBMCs; the
obtained 7.76Δ Ct positive value confirmed the infectivity of the virus recovered from the
PBMC samples. In contrast, Margarita RNA in group B in vitromock-infected PBMCs
remained undetectable even after ST inoculation. Furthermore, Margarita RNA load detection
Table 2. Swine persistently infected with the CSFV Catalonia strain are protected from CSFVMargarita strain infection in tissue samples.
Group A (CSFV acutely infected wild boars; 1–3) Group B (CSFV-superinfected wild boars; 4–6)
1 2 3 4 5 6
Tissues CSFV
RNA a
Margarita
RNA b
CSFV
RNA
Margarita
RNA
CSFV
RNA
Margarita
RNA
CSFV
RNA
Margarita
RNA
CSFV
RNA
Margarita
RNA
CSFV
RNA
Margarita
RNA
Spleen 18,57 17,70 17,2 17,90 17,09 16,23 21,4 32,91 20,35 36,15 20,85 Undet.
Liver 22,3 21,36 21,05 21,94 19,35 19,50 23,96 32,24 24,01 Undet. 25,05 Undet.
Mes. Ln.c 21,78 21,04 21,4 20,32 18,05 16,43 Not
det.g
Not det. 22,31 Undet. 22,76 Undet.
Pres. Ln.d 19,27 18,12 18,91 18,02 17,88 16,16 22,92 Undet.h 23,81 Undet. 25,15 Undet.
B.M.e 19,9 17,92 19,68 16,77 19,49 18,34 19,54 Undet. 22,75 Undet. 20,72 Undet.
M.
oblongataf
26,44 25,94 26,99 24,86 24,41 25,27 Not
det.
Not. Det. 24,4 Undet. 24,64 Undet.
Urine 31,08 28,49 17,95 18,94 31,76 28,77 20,05 Undet. Not.
Det
Not. Det. 21,77 Undet.
Lung 23,57 22,70 22,66 21,01 19,14 17,78 20,21 Undet. 19,84 Undet. 19,97 Undet.
Kidney 25,08 23,32 25,24 23,25 21,98 20,57 21,62 Undet. 22,55 Undet. 21,77 Undet.
Thymus 27,46 25,18 23,64 21,31 21,02 19,36 20,5 Undet. 21,23 Undet. 21,15 Undet.
Tonsil 20,33 19,91 21,36 19,06 18,4 16,36 22,87 Undet. 25,03 Undet. 21,49 Undet.
a Ct value detected with the generic CSFV q RT-PCR assay (37).
b Ct value detected with the speciﬁc CSFV RNA Margarita strain qRT-PCR assay.
c Mes. Ln = Mesenteric lymph node.
d Pres. Ln. = Prescapular lymph node.
e B.M. = Bone marrow.
f M. oblongata = Medulla oblongata.
g Not Det. = Not determined.
h Undet. = Undetected.
doi:10.1371/journal.pone.0149469.t002
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in group B in vitroMargarita-infected PBMC samples decreased after inoculation of ST cells,
corresponding to higher Ct values than those previously detected directly from PBMC extracts.
Remarkably, an 11.6 ΔCt value was found in the ST cells with Margarita in vitro inoculated
PBMCs from group B, relative to the value obtained in the ST cell extracts fromMargarita-
inoculated naïve PBMCs (Table 3). The whole protocol was repeated twice for animals 1
(group A), 4 and 5 (group B) in both SK6 and ST cells, supporting the results with similar Ct
values (data not shown). Similarly, the cells’ positive infection was confirmed by PLA testing,
although this test cannot differentiate between Cat01 and Margarita CSFV strains.
3.8. Sequence analysis could not detect CSFVMargarita RNA in tissues
from CSFV-superinfected animals
To detect the presence of CSFV RNA of both viral strains (Cat01 and/or Margarita) in the sera,
tonsil, and spleen of animals 1 and 3 (Group A) and 4 and 5 (Group B), the E2-gene fragment
reported by Lowings et al. [44] as a phylogenetic marker was amplified by end point RT-PCR
[45]. In all of the samples analysed from animals that developed the CSF acute form (Group
A), the sequence corresponding to the Margarita strain (AJ704817) used as the inoculum was
detected. Furthermore, the samples analysed from superinfected animals (Group B: CSFV Cat-
alonia 01 persistently infected inoculated with CSFV Margarita strain) only showed the
sequence corresponding to the Cat01 strain [30] (Fig 4).
4. Discussion
Despite its significance, the mechanisms of mutual exclusion by viral variants are far from
being completely understood, and the actual knowledge is basically derived from studies at the
cellular level in established cell lines [14, 16, 19, 49]. Very few reports have demonstrated the
Table 3. CSFV interference in the PBMCs from superinfected hosts.
Experimental groups
Naive CSFV acutely infected wild
boar 1 (10 dpi; group A)
CSFV-superinfected wild boar
5 (13 dpi; group B)
CSFV Ct a Speciﬁc Margarita
Ctb
CSFV
Ct
Speciﬁc Margarita
Ct
CSFV
Ct
Speciﬁc Margarita
Ct
PBMC extracts
Mock-infected PBMC Undetected Undetected 24.99 23.10 26.38 Undetected
CSFV Catalonia-infected PBMCs (MOI 0.1) 34.90 Undetected 25.86 23.61 25.60 Undetected
CSFV Margarita-infected PBMCs (MOI 0.1) 32.50 31.47 25.06 22.91 25.14 31.05
ST cell extracts
Mock Undetected Undetected 29.70 27.81 25.57 Undetected
CSFV Catalonia (MOI 0.1) 25.93 Undetected 29.37 27.95 28.67 Undetected
CSFV Margarita (MOI 0.1) 26.80 23.71 28.14 25.83 28.92 35.31
CSFV Margarita Δ CT value determination
PBMC extracts—ST cell extracts 7.76c -2.92c -4.26c
ST cell extracts—ST cell extracts from naïve
animals
2.12c 11.6c
a Ct value detected with the generic CSFV qRT-PCR assay (37).
bCt value detected with the speciﬁc CSFV RNA Margarita strain q RT-PCR assay.
cΔ Ct value.
doi:10.1371/journal.pone.0149469.t003
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phenomenon of SIE at the organism level, and, to our knowledge, these models have been lim-
ited to plant viruses, West Nile virus (WNV) in mosquitoes, and Peking duck hepatitis B virus
(DHBV) [50–52]. In addition, it has not yet been demonstrated in a mammalian host at the
systemic level.
Previous works have reported the capability of CSFV to generate postnatally persistent
infection in both domestic pigs and wild boars [5, 6]. Subsequently, it was also shown that post-
natally persistently infected pigs were unable to elicit a specific immune response to a CSFV
live attenuated vaccine and that the viral vaccine RNA was undetectable in any of the samples
analysed [7]. Against this background, we assessed the capacity of CSFV to generate SIE in
CSFV persistently infected swine. For that purpose, CSFV persistently infected wild boars were
inoculated with a CSFV strain that induce acute disease with a higher replication rate [29, 36].
Because pestiviruses are immunologically and genetically closely related, accurate serologi-
cal characterisation of CSFV isolates is impeded by the extensive cross-reactions observed
among Pestivirus members and the limited availability of MAbs capable of differentiating
among different CSFV isolates [27, 45, 53]. To differentiate the CSFVMargarita strain RNA
from the CSFV Cat01 strain RNA in the samples from the present study, a specific qRT-PCR
for Margarita strain RNA detection was developed. Thus, alongside the model of infection with
the Margarita strain, the qRT-PCR assay developed allowed for clear discernment of whether
there was actually a blockage that prevented susceptibility to infection by the second virus in
both the absence of clinical signs and the absence of molecular detection of the superinfecting
virus.
Notwithstanding the high infection rate of the Cat01 strain in persistently infected animals
from group B (primary virus infection), good health status was maintained after inoculation
with the Margarita CSFV virulent strain (secondary infection) in the absence of viral detection
Fig 4. Sequence analysis of the partial E2 sequence does not detect the CSFVMargarita RNA in the tissues from superinfected animals. The
Margarita and Cat01 viral strain sequences used as viral inocula in the animal infection experiments were considered as references. Sequences from sera,
tonsil and spleen samples from group A (CSFV acutely infected wild boars; 1, 3) and group B (CSF-superinfected wild boars; 4, 5) are shown. Differences in
the nucleotide sequences between the CSFVMargarita and Catalonia 01 strains are shown in grey and dark grey, respectively.
doi:10.1371/journal.pone.0149469.g004
CSFV Superinfection Exclusion in Swine
PLOS ONE | DOI:10.1371/journal.pone.0149469 February 26, 2016 12 / 19
in sera throughout the study, except in one animal at 13 dpi with a low Margarita strain RNA
load (animal 4). Despite the important role that neutralising antibodies play in CSFV protec-
tion [29, 54], complete absence of neutralising antibodies response was found after Margarita
strain infection in these animals. Similarly, absence of an IFN-γ-producing cell response
against CSFV or PHA was also observed. Considering the role played by IFN-γ in the control
of CSFV infection [34, 55] and the lack of responsiveness to IFN-γ-producing cells after PHA
stimulation, the CSFV-superinfected animals maintained a immunosuppression state similar
to that previously described in postnatal persistent infection [5, 6]. Previous work has proved
how the failure to induce optimal levels of the humoral and cellular responses after CSFV infec-
tion promoted the spread of the virus and its relationship with disease progression [29, 54]. In
this regard, the implications of the cellular and neutralising antibody response in clinical pro-
tection against the acute form in the CSFV-superinfected animals from this study are excluded.
Furthermore, no superinfecting virus excretion was detected in any of the animals from
Group B, whilst the high viral load generated by the strain that induced the persistent infection
(Cat01 strain or primary infection) was maintained until the end of the trial, supporting our
previous results [7]. In contrast, the CSFVMargarita strain generated the acute form of the dis-
ease in animals from group A, with high Margarita RNA loads in all of the samples analysed.
In addition, the failure of the humoral response in the pigs that developed acute CSF was previ-
ously described [29].
In addition to the adaptive immune response, the innate immune response to the virus, as
measured by type I IFN-α in the serum, also seemed to be impaired, in terms of IFN-α detec-
tion because IFN-α values were undetectable in the sera from postnatally persistently infected
wild boars after CSFV Margarita strain inoculation. At the same time, the progression of the
acute disease in group A was correlated with an increase in levels of endogenous IFN-α, as has
been previously described [29, 46, 56, 57]. The absence of an IFN-α response in the Cat01 per-
sistently infected animals after Margarita strain inoculation (secondary infection) probably was
due to the almost complete lack of Margarita strain replication in these animals. Otherwise,
specific CSFV-blockade phenomena for IFN-αmight be occurring. Efficient viral strategies to
escape the type I IFN-induced antiviral mechanisms have been described within Pestivirus. In
this regard, the viral RNA triggers IFN synthesis, and the viral RNase Erns inhibits IFN expres-
sion induced by extracellular viral RNA [58]. In addition, the viral protein Npro suppresses type
I IFN (IFN-α/β) induction by mediating proteasomal degradation of IFN regulatory factor 3
(IRF-3) [58–60]. For instance, in persistent infection, BVDVmaintains “self-tolerance” by
avoiding the induction of IFN, without compromising the IFN action against unrelated viruses
(“nonself”) [58]. In the case of CSFV-infected pigs, it has been recently demonstrated that func-
tional Npro significantly reduced local IFN-αmRNA expression responses at local sites of virus
replication [61]. These highly selective “self”models of evasion of the interferon defence system
might be key elements in the success of persistent infections and could promote, in addition,
the generation of SIE phenomena.
Previous reports have suggested that the availability of mammalian models for SIE in vivo is
hampered by the interferon response generated against the infecting virus in these species [11,
24]. It is noteworthy that CSFV postnatally persistently infected swine have shown an immu-
nosuppression state comprising a reduction in interferon responses (Types I and II) [5–7].
This immunological status might promote the maintenance of a high and constant CSFV load,
as already described, preventing second viral entry [5]. Nevertheless, further studies would be
needed to clarify the molecular mechanisms involved in this phenomenon.
At 13 dpi, low levels of Margarita RNA were detected only in some collected tissues from
persistently and superinfected wild boars (Group B), principally in animal 4, in which Marga-
rita RNA was detected from the spleen and liver, as well as in the serum. However, the level of
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Margarita RNA detection was approximately fifteen times less than the acutely infected ani-
mals from group A (Table 2). The Margarita RNA levels found in the superinfected animals
might be correlated with the low Margarita strain viral loads in some macrophages in these tis-
sues [62].
In contrast, despite PBMCs being a well-known target for CSFV viral replication [62], after
in vitro assay, the presence of CSFVMargarita RNA could not be detected in either the PBMCs
or ST cell extracts from Group B. Additionally, the in vitro superinfection of isolated PBMCs
failed when they were derived from persistently infected piglets but were clearly positive for
assays with cells from naïve animals, as demonstrated by means of calculated ΔCt values, sup-
porting that PBMCs from persistently infected animals were substantially protected from
superinfection after in vitro inoculation with the Margarita virus strain. These results suggest
that SIE still occurs at the tissue level (Table 3). In contrast, the Margarita strain RNA could
not be detected after the sequence analyses of the samples from persistently infected Marga-
rita-inoculated animals (Group B) nor even in the tonsil, one of the main targets for CSFV rep-
lication [3, 63]. Nevertheless, next-generation sequence analyses would be of great interest to
analyse these samples in detail, emphasising the spleen and liver tissues that were also positive
for RNAMargarita strain detection after superinfection.
Altogether, although it is a very complex mechanism, if compared with the acutely infected
group A, these results showed that a phenomenon of CSFV SIE occurred at the systemic level.
Nevertheless, the colonisation of a multi-cellular host is a complex process during which the
viral load can dramatically change in different organs and at different stages of the infection,
and not all of the potential target cells are infected in persistently infected animals despite the
high viral load generated by the Cat01 CSFV strain in persistently infected animals [5, 6]. Illus-
trative examples include some of the works performed to demonstrate SIE at the cellular level
because some cells uninfected by one viral primary infection are subsequently infected by the
second viral infection [11, 50]. In contrast, the implications of other mechanisms in the host
cannot be excluded, and it remains unclear whether the observed phenomenon is really due to
a blockage at the level of infection of cells. This was precisely in the case of a citrus tristeza
virus (CTV) SIE model, wherein a CTV protein (p33) was required to mediate SIE at the
organism level but that did not appear to be implicated in exclusion at the cellular level [50].
Overall, our results suggested efficient suppression of viral superinfection in a mammalian
host, especially in the absence of IFN-α, indicating a lack of innate immune mechanisms. Con-
sidering the role of this phenomenon from an evolutionary standpoint, their implications
within an epidemic situation might be relevant to the evolution and phylogeny of CSFV.
Although this phenomenon must be studied in greater depth, the possible outcome for the gen-
eration of new CSFV strains circulating in an endemic situation and the impact on disease con-
trol, including vaccination with live attenuated vaccines, cannot be underrated.
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